Published Oct 30, 2026, 5:00 AM ET · Updated 14 days ago · 1 source
Eating disorders are on the rise. GLP-1s could make things worse.
MIT Technology Review
·
Original Report
INFERY
GLP-1 weight-loss drugs are one of the biggest biotech breakthroughs of the last decade. But to some clinical psychologists, they can represent something more sinister—a potential trigger for eating disorders. A new report suggests that the global incidence of anorexia nervosa and bulimia nervosa shot up between 1990 and 2023—by a whopping 71%. By 2023,…